OptiNose (NASDAQ:OPTN) — Stock Price
OptiNose (NASDAQ:OPTN) is currently trading at $9.60 USD, up 0.00% today. Over the past 52 weeks, shares have ranged between $9.60 and $9.60. This page tracks OptiNose's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see OptiNose (OPTN) total market value.
OptiNose (OPTN) Stock Price Chart — Daily History & Trading Volume
The chart below tracks OptiNose's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Daily price history is not currently available for OptiNose.
OptiNose Income Statement — Revenue, Profit & Earnings by Year
OptiNose's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | $78.23 Million | $70.99 Million | $76.28 Million | $74.65 Million | $49.12 Million |
| Cost of Revenue | $7.23 Million | $8.63 Million | $9.26 Million | $9.15 Million | $7.52 Million |
| Gross Profit | $71.00 Million | $62.35 Million | $67.01 Million | $65.50 Million | $41.60 Million |
| Research & Development | $3.85 Million | $5.30 Million | $15.26 Million | $25.32 Million | $23.38 Million |
| SG&A | $83.46 Million | $79.80 Million | $107.65 Million | $106.63 Million | $105.44 Million |
| Total Operating Expenses | $87.31 Million | $85.10 Million | $122.91 Million | $131.95 Million | $128.82 Million |
| Operating Income | $-16.32 Million | $-22.75 Million | $-55.90 Million | $-66.45 Million | $-87.22 Million |
| EBITDA | $-1.20 Million | $-15.55 Million | $-55.36 Million | $-65.80 Million | $-85.76 Million |
| EBIT | $-1.48 Million | $-15.96 Million | $-55.90 Million | $-66.45 Million | $-87.22 Million |
| Interest Expense | $20.06 Million | $19.53 Million | $16.84 Million | $15.97 Million | $13.01 Million |
| Income Before Tax | $-21.54 Million | $-35.48 Million | $-74.83 Million | $-82.30 Million | $-99.79 Million |
| Income Tax Expense | — | $234.10K | $1.56 Million | $-646.00K | $-1.46 Million |
| Net Income | $-21.54 Million | $-35.48 Million | $-76.39 Million | $-81.65 Million | $-98.33 Million |
OptiNose Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes OptiNose's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $128.78 Million | $107.73 Million | $144.22 Million | $166.07 Million | $188.81 Million |
| Total Current Assets | $125.84 Million | $105.33 Million | $140.48 Million | $160.38 Million | $144.16 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $26.39 Million | $19.93 Million | $33.93 Million | $35.45 Million | $23.39 Million |
| Inventory | $11.46 Million | $8.05 Million | $9.44 Million | $11.85 Million | $9.04 Million |
| Property, Plant & Equipment | — | — | $795.00K | $1.35 Million | $2.03 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $169.15 Million | $194.34 Million | $200.85 Million | $187.84 Million | $182.03 Million |
| Total Current Liabilities | $162.81 Million | $176.52 Million | $178.73 Million | $59.23 Million | $52.17 Million |
| Long-term Debt | — | — | — | $126.42 Million | $125.20 Million |
| Net Debt | $44.48 Million | $56.54 Million | $36.93 Million | $20.20 Million | $-18.95 Million |
| Total Stockholder Equity | $-40.36 Million | $-86.61 Million | $-56.62 Million | $-21.77 Million | $6.79 Million |
| Retained Earnings | $-741.92 Million | $-720.38 Million | $-684.89 Million | $-610.06 Million | $-527.76 Million |
OptiNose Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how OptiNose generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-44.89 Million | $-20.53 Million | $-67.65 Million | $-76.94 Million | $-86.21 Million |
| Capital Expenditures | $72.00K | $328.00K | $63.00K | $167.00K | $546.00K |
| Free Cash Flow | $-44.75 Million | $-20.86 Million | $-67.71 Million | $-77.10 Million | $-86.75 Million |
| Investing Cash Flow | — | — | $-63.00K | $-62.00K | $-546.00K |
| Financing Cash Flow | $55.55 Million | $300.00K | $51.44 Million | $43.32 Million | $83.81 Million |
| Dividends Paid | $0.00 | $0.00 | — | — | $865.00K |
| Stock-Based Compensation | $6.46 Million | $5.20 Million | $8.88 Million | $10.00 Million | $10.35 Million |
| Depreciation | $283.00K | $402.00K | $532.00K | $646.00K | $1.46 Million |
| Change in Cash | $10.80 Million | $-20.56 Million | $-16.27 Million | $-33.66 Million | $-2.99 Million |
OptiNose Earnings History — EPS Actual vs. Analyst Estimates
Track OptiNose's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 12, 2025 | -1.92 | -0.11 | -1645.45% |
| Mar 05, 2025 | -0.03 | -0.84 | +96.43% |
| Nov 07, 2024 | 0.00 | -0.05 | +104.60% |
| Aug 08, 2024 | -0.05 | -0.08 | +37.50% |
| May 14, 2024 | -0.12 | -0.11 | -9.09% |
| Mar 07, 2024 | -0.09 | -0.09 | +0.00% |
| Nov 09, 2023 | -0.08 | -0.09 | +11.11% |
| Aug 10, 2023 | 0.02 | -0.11 | +118.18% |